2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
43
Myelodysplastic Syndromes
41
Leukemia
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Lymphoma, Non-Hodgkin
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Leukemia, Lymphocytic, Chronic, B-Cell
23
Lymphoma
22
Hodgkin Disease
22
Hematologic Neoplasms
22
Multiple Myeloma
18
Graft vs Host Disease
14
Myeloproliferative Disorders
13
Primary Myelofibrosis
12
Leukemia, Myelomonocytic, Juvenile
11
Lymphoma, Mantle-Cell
9
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Follicular
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myelomonocytic, Chronic
7
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myeloid, Accelerated Phase
6
Congenital Abnormalities
6
Burkitt Lymphoma
6
Waldenstrom Macroglobulinemia
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Leukemia, Myeloid, Chronic-Phase
5
Blast Crisis
5
Interventions
Cyclophosphamide
18
ofatumumab
14
fludarabine
12
Rituximab
11
ibrutinib
10
fludarabine phosphate
9
acalabrutinib
7
obinutuzumab
6
Lenalidomide
6
Bendamustine Hydrochloride
6
venetoclax
5
pirtobrutinib
4
Vincristine
4
Mesna
4
Melphalan
4
Immunotherapy, Adoptive
4
Whole-Body Irradiation
3
Mycophenolic Acid
3
Chlorambucil
3
Bortezomib
3
Alemtuzumab
3
spebrutinib
2
navitoclax
2
idelalisib
2
Tacrolimus
2
Tablets
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
KW-2478
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
thymoglobulin
×
Clear all
NCT03852407
2022-10-12
HLA
University of Liege
Phase 2
Recruiting
114 enrolled